Clinical trials are an essential component of drug development for new cancer treatments, yet the information required to determine a patient’s eligibility for enrollment is scattered in large amounts of unstructured text. Genomic biomarkers…
Continue Reading
Data sharing technology company Datavant has expanded its collaboration with pharmaceutical company Boehringer Ingelheim to support Boehringer’s real-world evidence initiatives. The extended collaboration aims to leverage Datavant’s privacy-preserving tokenization and data connectivity technologies to strengthen…
Continue Reading
What You Should Know:
– Precision for Medicine, a provider of next-generation drug development research and services, and PathAI, a global leader in digital pathology, announced a strategic collaboration today.
– The partnership aims to jointly…
Continue Reading
The Evolving Orphan Drug Landscape
Once considered specialized treatments for rare conditions, orphan drugs are now challenging the dominance of mainstream medications in the pharmaceutical industry. According to two recent Evaluate reports—”Are Orphans That Different?”…
Rajneesh Patil Vice President, Digital Innovation at IQVIA
Nicholas Whitney, Senior Director, Site Suite, IQVIA Technologies
In recent years, clinical research and development stakeholders have put tremendous effort into improving patient-centered clinical trials, where patients feel…
Continue Reading
Source: Icahn School of Medicine at Mount Sinai
What You Should Know:
– The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a pioneering initiative that leverages…
Continue Reading
What You Should Know:
– The pharmaceutical research and development (R&D) sector is experiencing a significant upswing, with projected returns on investment climbing to 5.9% in 2024, according to a new report by Deloitte.
– This…
Continue Reading
Regulatory acceptance of Digital Health Technology (DHT) -derived endpoints can be a long, multifaceted and costly process. Success relies on establishing a global strategy as part of the development program including health authority consultations…
Continue Reading
What You Should Know:
– Validose, a 10XBeta Venture Studio portfolio company pioneering precision medication delivery, announced today the successful close of a $2 million pre-seed funding round.
– The round was led by Peter Bauer’s Family Office as part…
Continue Reading
Sujay Jadhav, Verana Health CEO
In recent years, regulatory bodies, such as the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have increasingly emphasized the use of real-world data (RWD) in clinical…
Continue Reading
